{"schema_version":"secwatch.filing_event.v1","accession":"0000721371-26-000017","form_type":"8-K","ticker":"CAH","cik":"0000721371","company_name":"CARDINAL HEALTH INC","filed_at":"2026-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.678237+00:00","generated_at":"2026-05-15T01:25:08.576879+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cardinal Health Q3 revenue +11% to $60.9B, non-GAAP EPS $3.17 (+35%), raises FY26 outlook","bullets":["Non-GAAP EPS $3.17, up 35% YoY; GAAP EPS $1.69, down 20% on $184M goodwill impairment in Navista & ION.","Revenue $60.9B, +11%; Pharmaceutical & Specialty segment profit +18% to $784M.","FY26 non-GAAP EPS guidance raised to $10.70-$10.80; adjusted free cash flow raised to $3.3B-$3.7B.","Global Medical segment profit fell 36% to $25M due to tariff impact; Other segment profit up 34% to $179M.","Completed $250M accelerated share repurchase; YTD buybacks $1.0B; leverage ratio lowered to 3.0X."],"urls":{"canonical":"https://secwatch.observer/filing/0000721371-26-000017","json":"https://secwatch.observer/filing/0000721371-26-000017.json","markdown":"https://secwatch.observer/filing/0000721371-26-000017.md","text":"https://secwatch.observer/filing/0000721371-26-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/0000721371-26-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/cah-20260430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T01:25:08.576879+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1983ba4f5c4a9d9e7458bd61c92e501993e5f86e","claim":"CARDINAL HEALTH INC reported FY26 results: EPS $10.70 to $10.80. Guidance raised.","evidence_excerpt":"Cardinal Health is raising and narrowing its fiscal year 2026 guidance for non-GAAP diluted EPS attributable to Cardinal Health, Inc. to a range of $10.70 to $10.80 (+30% to +31% growth).","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/0000721371-26-000017-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"FY26"},{"label":"EPS","value":"$10.70 to $10.80"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}]},{"claim_id":"3bafa36ec2c89bcc18de3fa066f2d9d121d0e1b6","claim":"CARDINAL HEALTH INC reported Q3 FY26 results: revenue $60.9 billion, net income $750 million, EPS $3.17.","evidence_excerpt":"Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2026 revenues of $60.9 billion, an increase of 11% from the third quarter of fiscal year 2025. Third quarter GAAP operating earnings decreased 30% to $509 million and GAAP diluted earnings per share (EPS) decreased 20% to $1.69","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/0000721371-26-000017-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Q3 FY26"},{"label":"Revenue","value":"$60.9 billion"},{"label":"Net income","value":"$750 million"},{"label":"EPS","value":"$3.17"},{"label":"Result","value":"reported results"}]},{"claim_id":"3bafa36ec2c89bcc18de3fa066f2d9d121d0e1b6","claim":"CARDINAL HEALTH INC reported Q3 FY26 results: revenue $60.9 billion, net income $750 million, EPS $3.17.","evidence_excerpt":"to this report. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook • Revenue increased 11% to $60.9 billion • GAAP 1 operating earnings decreased 30% to $509 million; GAAP diluted EPS decreased 20% to $1.69 • Non-GAAP operating earnings increased 18% to $956 million; non-GAAP diluted","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/721371/000072137126000017/0000721371-26-000017-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Q3 FY26"},{"label":"Revenue","value":"$60.9 billion"},{"label":"Net income","value":"$750 million"},{"label":"EPS","value":"$3.17"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}